Eli Shani - Aug 15, 2021 Form 3 Insider Report for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)

Role
EVP,Global Marketing&Portfolio
Signature
/s/ Dov Bergwerk as attorney-in-fact for Eli Shani
Stock symbol
TEVA
Transactions as of
Aug 15, 2021
Transactions value $
$0
Form type
3
Date filed
8/19/2021, 04:03 PM
Next filing
Mar 2, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding TEVA Ordinary Shares 9.09K Aug 15, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding TEVA Restricted Share Units Aug 15, 2021 Ordinary Shares 6.35K Direct F1, F2, F3
holding TEVA Restricted Share Units Aug 15, 2021 Ordinary Shares 1.58K Direct F1, F3, F4
holding TEVA Restricted Share Units Aug 15, 2021 Ordinary Shares 23.6K Direct F1, F3, F5
holding TEVA Restricted Share Units Aug 15, 2021 Ordinary Shares 15.9K Direct F1, F3, F6
holding TEVA Stock Options (right to buy) Aug 15, 2021 Ordinary Shares 16.5K $22.48 Direct F1, F7
holding TEVA Stock Options (right to buy) Aug 15, 2021 Ordinary Shares 13K $34.70 Direct F1, F8
holding TEVA Stock Options (right to buy) Aug 15, 2021 Ordinary Shares 13K $53.50 Direct F1, F9
holding TEVA Stock Options (right to buy) Aug 15, 2021 Ordinary Shares 14.3K $60.21 Direct F1, F10
holding TEVA Stock Options (right to buy) Aug 15, 2021 Ordinary Shares 15K $48.76 Direct F1, F11
holding TEVA Stock Options (right to buy) Aug 15, 2021 Ordinary Shares 4.17K $38.08 Direct F1, F12
holding TEVA Stock Options (right to buy) Aug 15, 2021 Ordinary Shares 2.67K $44.59 Direct F1, F13
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
F2 Restricted share units were granted on March 4, 2019, with 3,173 vesting on each of March 4 2022 and March 4, 2023.
F3 Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
F4 Restricted share units were granted on August 10, 2018, with 1,581 vesting on August 10, 2022.
F5 Restricted share units were granted on March 5, 2021, with 5,896 vesting on each of March 5, 2022, March 5, 2023 and March 5, 2024 and 5,898 vesting on March 5, 2025.
F6 Restricted share units were granted on February 28, 2020, with 5,311 vesting on each of February 28, 2022 and February 28, 2023 and 5,312 vesting on February 28, 2024.
F7 Stock options were granted on August 10, 2018, with 4,152 vesting on each of August 10, 2019, August 10, 2020 and August 10, 2021 and 4,128 vesting on August 10, 2022.
F8 Stock options were granted on March 3, 2017, with 3,250 vested on each of March 3, 2018, March 3, 2019 and March 3, 2020 and 3,252 vested on March 3, 2021.
F9 Stock options were granted on March 17, 2016, with 3,251 vested on each of March 17, 2017, March 17, 2018 and March 17, 2019 and 3,252 vested on March 17, 2020.
F10 Stock options were granted on March 12, 2015, with 3,563 vested on each of March 12, 2016, March 12, 2017, March 12, 2018 and March 12, 2019.
F11 Stock options were granted on March 12, 2014, with 5,000 vested on each of March 12, 2015 and March 12, 2016 and 5,002 vested on March 12, 2017.
F12 Stock options were granted on February 24, 2013, with 4,170 having vested on February 24, 2016.
F13 Stock options were granted on February 24, 2012, with 2,669 vested on February 24, 2016.